Nordic Webinar on Complement targeted therapy
Wednesday 18 March
15:30 – 17:00
About the event
Organizer: Bonnier Healthcare Nordic c/o Dagens Medisin AS
Nordic Webinar on Complement targeted therapy
C3-Targeted Therapy in C3G and Primary IC-MPGN
Program:
Moderator: Professor Stefan Jacobson, Department of Nephrology, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
A deeper dive into the VALIANT phase 3 study data
Professor in Nephrology, Fadi Fakhouri, Head of Nephrology and Hypertension, Lausanne University Hospital “CHUV”, Switzerland (digital)
Where Does Complement Inhibition Fit Within the Treatment Paradigm for C3G, Primary IC-MPGN, ANCA-Associated Vasculitis and igAN?
Professor in Nephrology, Annette Bruchfeld, FERA, Senior Physician Linköping
A caregiver perspective, and a multi-disciplinary approach to evidence generation
Founder, Marianne Silskjær Nielsen, CompCure
Panel discussion and short summary
Nordic Webinar on Complement targeted therapy
Wednesday 18 March
15:30 – 17:00
About the event
Organizer: Bonnier Healthcare Nordic c/o Dagens Medisin AS
Nordic Webinar on Complement targeted therapy
C3-Targeted Therapy in C3G and Primary IC-MPGN
Program:
Moderator: Professor Stefan Jacobson, Department of Nephrology, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
A deeper dive into the VALIANT phase 3 study data
Professor in Nephrology, Fadi Fakhouri, Head of Nephrology and Hypertension, Lausanne University Hospital “CHUV”, Switzerland (digital)
Where Does Complement Inhibition Fit Within the Treatment Paradigm for C3G, Primary IC-MPGN, ANCA-Associated Vasculitis and igAN?
Professor in Nephrology, Annette Bruchfeld, FERA, Senior Physician Linköping
A caregiver perspective, and a multi-disciplinary approach to evidence generation
Founder, Marianne Silskjær Nielsen, CompCure
Panel discussion and short summary